RFB002H
Drug
Novartis Pharma AG
Total Payments
$95,888
Transactions
21
Doctors
5
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $57,199 | 11 | 3 |
| 2017 | $38,689 | 10 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $92,246 | 11 | 96.2% |
| Travel and Lodging | $3,372 | 4 | 3.5% |
| Food and Beverage | $270.30 | 6 | 0.3% |
Top Doctors Receiving Payments for RFB002H
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Ophthalmology | Royal Oak, MI | $47,156 | 4 |
| , M.D | Ophthalmology | Portland, OR | $32,389 | 5 |
| , MD | Ophthalmology | Amherst, NY | $16,278 | 10 |
| , M.D., PH.D | Ophthalmology | Sacramento, CA | $32.81 | 1 |
| , MD | Ophthalmology | Salt Lake City, UT | $32.81 | 1 |
Ad
Manufacturing Companies
- Novartis Pharma AG $95,888
Product Information
- Type Drug
- Total Payments $95,888
- Total Doctors 5
- Transactions 21
About RFB002H
RFB002H is a drug associated with $95,888 in payments to 5 healthcare providers, recorded across 21 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2018. In 2018, $57,199 was paid across 11 transactions to 3 doctors.
The most common payment nature for RFB002H is "Consulting Fee" ($92,246, 96.2% of total).